DK0533213T3 - Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis - Google Patents

Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis

Info

Publication number
DK0533213T3
DK0533213T3 DK92119073.2T DK92119073T DK0533213T3 DK 0533213 T3 DK0533213 T3 DK 0533213T3 DK 92119073 T DK92119073 T DK 92119073T DK 0533213 T3 DK0533213 T3 DK 0533213T3
Authority
DK
Denmark
Prior art keywords
azelastine
psoriasis
control
active agent
glycerol ethers
Prior art date
Application number
DK92119073.2T
Other languages
Danish (da)
English (en)
Inventor
Juergen Dr Engel
Michael Dr Molliere
Istvan Dr Szelenyi
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0533213T3 publication Critical patent/DK0533213T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/18—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels
    • E02F3/20—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels
    • E02F3/205—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels with a pair of digging wheels, e.g. slotting machines
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
    • E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F3/00—Dredgers; Soil-shifting machines
    • E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
    • E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
    • E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
    • E02F3/92—Digging elements, e.g. suction heads
    • E02F3/9212—Mechanical digging means, e.g. suction wheels, i.e. wheel with a suction inlet attached behind the wheel
DK92119073.2T 1989-01-11 1990-01-03 Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis DK0533213T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3900607 1989-01-11

Publications (1)

Publication Number Publication Date
DK0533213T3 true DK0533213T3 (da) 1994-10-17

Family

ID=6371863

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90100071.1T DK0378086T3 (da) 1989-01-11 1990-01-03 Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme
DK92119073.2T DK0533213T3 (da) 1989-01-11 1990-01-03 Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK90100071.1T DK0378086T3 (da) 1989-01-11 1990-01-03 Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme

Country Status (15)

Country Link
US (1) US5110814A (de)
EP (2) EP0533213B1 (de)
JP (1) JP2991733B2 (de)
AT (2) ATE111735T1 (de)
AU (1) AU618443B2 (de)
CA (1) CA2007480C (de)
DE (3) DE4000070A1 (de)
DK (2) DK0378086T3 (de)
EG (1) EG19912A (de)
ES (2) ES2061307T3 (de)
HK (2) HK50495A (de)
IE (1) IE65336B1 (de)
MC (1) MC2078A1 (de)
PT (1) PT92821B (de)
SG (2) SG30593G (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
NL9201438A (nl) * 1992-08-11 1994-03-01 Prospa Bv Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen.
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
DE10028638A1 (de) 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
AU2004285284B2 (en) * 2003-10-31 2010-03-25 Hexal Ag A process for the preparation of an active-ingredient-containing formulation with a coating
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
SI2377557T1 (sl) 2004-11-24 2017-02-28 Meda Pharmaceuticals Inc. Sestavki, ki obsegajo azelastin, in postopki njihove uporabe
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
NZ712180A (en) 2013-03-13 2017-01-27 Flatley Discovery Lab Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis
US10835584B2 (en) * 2016-06-17 2020-11-17 Nuvothera, Inc. Systems for treating dermal inflammatory conditions
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11938139B2 (en) * 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840606A (en) * 1969-12-05 1974-10-08 Oreal Process of producing mono and polyhydroxyl ethers
CH572914A5 (de) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs

Also Published As

Publication number Publication date
IE900098L (en) 1990-07-11
EP0378086B1 (de) 1994-10-26
PT92821A (pt) 1990-07-31
CA2007480A1 (en) 1990-07-17
EP0533213B1 (de) 1994-09-21
SG30593G (en) 1995-09-18
DE59007288D1 (de) 1994-10-27
ES2063841T3 (es) 1995-01-16
EG19912A (en) 1996-05-31
EP0533213A1 (de) 1993-03-24
HK50595A (en) 1995-04-13
DE4000070A1 (de) 1990-07-12
EP0378086A2 (de) 1990-07-18
PT92821B (pt) 1995-12-29
DE59007531D1 (de) 1994-12-01
SG30591G (en) 1995-09-18
CA2007480C (en) 1995-08-15
AU618443B2 (en) 1991-12-19
ATE113208T1 (de) 1994-11-15
JPH02288827A (ja) 1990-11-28
ATE111735T1 (de) 1994-10-15
AU4786290A (en) 1990-07-19
US5110814A (en) 1992-05-05
JP2991733B2 (ja) 1999-12-20
EP0378086A3 (de) 1991-02-06
DK0378086T3 (da) 1994-12-12
ES2061307T3 (es) 1994-12-01
MC2078A1 (fr) 1991-01-07
HK50495A (en) 1995-04-13
IE65336B1 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
DK0533213T3 (da) Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis
NO157020C (no) AnalogifremgangsmŸte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater.
NO924433D0 (no) Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse
DK175680A (da) Farmaceutisk praeparat i form af en polyacrylatfilm og fremgangsmaade til dets fremstilling
NO151362C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater.
AR229022A1 (es) Procedimiento para la elaboracion de derivados del alcohol 1-alfa-(n-(carbamoil-hidroxi-fenoxi)-alquilenaminometil-arilico
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
DK217585A (da) Farmaceutisk middel til behandling af neoplastiske sygdomstilstande
NO924045D0 (no) Anti-inflammatoriske hydroksamsyrer og n-hydroksyurinstoffer
DK10488A (da) Benzen-derivater med antiinflammatorisk virkning og fremgangsmaade til fremstilling deraf
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
IT8021795A0 (it) Derivati del 5h-furanone-2 e del3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica.
DK627289D0 (da) Anvendelse af bicyclononanderivater
ITMI920608A1 (it) Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
DK631989D0 (da) Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
DK484784D0 (da) Hidtil ukendte 2-tolylmorpholinderivater, der er nyttige som farmaceutiske midler
NO153848C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(arylthioalkyl)-n[-(aminoalkyl)-ureaderivater.
ES2072462T3 (es) Nuevas sales del acido 2-(2,6-dicloroanilino)fenilacetico, procedimiento para su elaboracion y uso de las mismas en preparados farmaceuticos de uso topico.
DK69784D0 (da) Pharmaceutisk komposition til behandling af psoriasis og beslaegtede lidelser
IT1102304B (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare
IT1055702B (it) Procedimento per la fabbricazione di lastre doppie di calcestruzzo e dispositivo per l'esecuzione del procedimento
NO147069C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-difluor-methyl-6,7-methylendioxy-1,4-dihydro-4-oxo-3-kinolincarboxylsyre og derivater derav
NO832134L (no) Anordning for behandling av saar i kroppsvev hos pasienter ved hjelp av gass.